Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Director departure
CLOVER HEALTH INVESTMENTS, CORP. (CLOV) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 4 Sharp Aric R (CEO of Value-Based Care) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 7,037 shares @ $1.39, valued at $9.8k
08/09/2023 4 Toy Andrew (CEO) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 277,720 shares @ $1.33, valued at $369.4k
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Clover Health Reports Strong Second Quarter 2023 Results&#59; Highlights Improved Financial Performance and Guidance Ranges Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2%, bringing first half MCR to 81.9%"
08/03/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Clover Health Regains Compliance with NASDAQ Minimum Bid Price Requirement"
08/03/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
07/21/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2023 SC 13G/A BlackRock Inc. reports a 2% stake in CLOVER HEALTH INVESTMENTS CORP CLA
06/30/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
06/16/2023 4 Reynoso Jamie L. (CEO of Medicare Advantage) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 7,776 shares @ $0.94, valued at $7.3k
06/16/2023 4 Martin Joseph Richards (General Counsel) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 98,827 shares @ $0.94, valued at $92.9k
06/16/2023 4 Wai Conrad (Chief Technology Officer) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 86,763 shares @ $0.94, valued at $81.6k
06/16/2023 4 Sharp Aric R (CEO of Value-Based Care) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 28,148 shares @ $0.93, valued at $26.2k
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/08/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/16/2023 4 Kouzoukas Demetrios L. (Director) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Granted 36,585 shares @ $0
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "Clover Health Reports First Quarter 2023 Financial Results Insurance revenue grew by 14% over Q1’22"
04/28/2023 4 Garipalli Vivek (Executive Chairperson) has filed a Form 4 on CLOVER HEALTH INVESTMENTS, CORP. /DE
Txns: Paid exercise price by delivering 1,569,594 shares @ $1.01, valued at $1.6M
Exercised 3,342,698 restricted stock units @ $0
Exercised 3,342,698 options to buy @ $0
Exercised 1,569,594 options to buy @ $0
04/27/2023 3/A Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
04/26/2023 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
04/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/24/2023 8-K Quarterly results
04/21/2023 8-K Quarterly results
04/20/2023 8-K Quarterly results
04/03/2023 3 Wai Conrad (Chief Technology Officer) has filed a Form 3 on CLOVER HEALTH INVESTMENTS, CORP. /DE
03/17/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "BOARD OBSERVER AGREEMENT"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy